| Ytd | 24.90% | |
| 1y | 111.27% |
| Open | 38.90 | Prev Close | 39.19 | Low | 38.66 | High | 39.38 | Mkt Cap | 45.46B |
| Vol | 5.47M | Avg Vol | 5.31M | EPS | 0.60 | P/E | 64.97 | Forward P/E | 12.60 |
| Beta | 0.80 | Short Ratio | 7.38 | Inst. Own | 22.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 11-28 | Earning | 11-04 | 50-d Avg | 35.35 | 200-d Avg | 33.15 | 1yr Est | 42.00 |
TEVA News
MONTPELLIER, France--(BUSINESS WIRE)--Medincell's partner Teva presented new data on investigational
New data revealed that healthcare providers prioritize drowsiness risk, duration of available data d
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva
New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva
In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half o
PARSIPPANY, N.J., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva
The U.S. FDA approved Ocrevus for paediatric RMS patients in May 2026. A final decision from the Eur
These three stocks are seeing some of the most unusual options volume today
Takeda Pharmaceutical (NYSE: TAK - Get Free Report) and Teva Pharmaceutical Industries (NYSE: TEVA -
Teva Pharmaceutical Industries (NYSE: TEVA) said its "Pivot to Growth" strategy has moved into its s
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) had a busy week that included a major debt refinanci
Teva Pharmaceutical Industries had a busy week that included a major debt refinancing, a NYSE tradin
Teva Pharmaceutical Industries NYSE: TEVA CEO Richard Francis said the company has progressed from t
Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthca
Teva Pharmaceutical Industries NYSE: TEVA said its “Pivot to Growth” strategy has moved into its sec
PARSIPPANY, N.J. and TEL AVIV, Israel, Sept.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it s
Leerink Partners analyst Daniel Clark initiates coverage on Teva Pharmaceutical Indus (NYSE:TEVA)
UBS analyst Ashwani Verma maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises t
Teva reports positive Phase 2a results for TEV '408, successfully preventing gluten-induced inte
Teva Pharma is trading higher after announcing positive topline results from a Phase 2a study of TEV
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive topline results f
Trump secures drug pricing deals with nine pharma companies as Kennedy reveals intense pressure from
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),
https://www.whitehouse.gov/fact-sheets/2026/08/fact-sheet-president-donald-j-trump-announces-deal-wi
BioXcel Chapter 11 sends BTAI shares sharply lower as Teva becomes the stalking horse bidder for IGA